Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03725241 · ClinicalTrials.gov registry record · NA

Effects of Glutathione on Immunity in Individuals Training for a Marathon

A NA study of Healthy, sponsored by University of North Texas, Denton, TX.

Completed
Registry status
NA
Development phase
84
Enrollment target
1
Study location

NCT03725241: Completed NA study of Healthy, sponsored by University of North Texas, Denton, TX.

NCT03725241 is a NA study of Healthy that has completed, run by University of North Texas, Denton, TX. The registered enrollment target is 84 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03725241, a NA study of Healthy, has completed, sponsored by University of North Texas, Denton, TX.

COMPLETED
Registry status
NA
Development phase
84 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to determine the effects of glutathione supplement on the immune cell response and symptomatology of upper respiratory health, and antioxidant capacity in healthy people in exercise-induced model.

Primary Outcome

CBC will be drawn and white blood cell count will be evaluated as an indicator of infection.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo Supplement
  • DIETARY_SUPPLEMENT Glutathione Supplement

Study Locations (1)

Texas

  • University of North Texas - Denton

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2018-10-29
Est. Completion 2020-05-01
Phase NA

What the finished NCT03725241 record still lists

NCT03725241 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (87% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo Supplement is the first listed.

NCT03725241 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT03725241 about?

NCT03725241 is a clinical study titled "Effects of Glutathione on Immunity in Individuals Training for a Marathon". The aim of this study is to determine the effects of glutathione supplement on the immune cell response and symptomatology of upper respiratory health, and antioxidant capacity in healthy people in exercise-induced model.

What is the current status of trial NCT03725241?

This trial is currently completed. It is a NA study. The enrollment target is 84 participants. The study started on 2018-10-29. Estimated completion is 2020-05-01.

What conditions does trial NCT03725241 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT03725241?

The interventions under investigation include: Placebo Supplement (DIETARY_SUPPLEMENT), Glutathione Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT03725241?

This trial is sponsored by University of North Texas, Denton, TX, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03725241 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03725241's enrollment target sits among peer trials

84 267th of 1090 higher than 821 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02391519 · 84 participants

    Effects of High Altitude on AMPK Activation

  • NCT03838536 · 84 participants · NA

    Synergistic Activity of Human Milk Nutrients and Infant Cognition

  • NCT03884075 · 84 participants · Phase 2

    Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)

  • NCT03894917 · 84 participants

    Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03725241, the US trial registry maintained by the National Library of Medicine. NCT03725241 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.